Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
about
Successful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitor.A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains.Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4.Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010.Computer-Aided Approaches for Targeting HIVgp41.An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.Precisely Designed Isopeptide Bridge-Crosslinking Endows Artificial Hydrolases with High Stability and Catalytic Activity under Extreme Denaturing Conditions.Update on the development of HIV entry inhibitors
P2860
Q30937880-F3C7D7F6-9007-417D-82B9-3A44A3A47C0CQ33622229-C11BD653-B1FA-4453-A5DE-A558DA319B1DQ33826278-E89C765B-16E3-4807-883F-DDDEBF23512DQ33925615-1F8554E8-E884-4A08-AE45-169A90A0A2FCQ34057606-8ACFD2D3-D4E2-46E1-B9FA-F5490838D4B7Q34151017-B1170633-1A99-463F-9EE9-AD8D821AC6B0Q34536817-B023F832-5343-48A6-92E4-08A4E873734DQ36491733-AFA8ABC4-4CFA-4E35-9519-1E8FF1C25095Q36949390-8D57EB58-F8FC-4DFF-A3E9-B82E6733460FQ37258274-07CD521A-EF4E-434A-8A7D-E39A1AECE167Q37845842-FD93B42A-1E91-42BA-8DA7-928C029BC3A8Q38111393-3A967A0F-3D22-4247-B315-88888928109FQ42732016-80459AF6-3660-4F8D-9C28-E0CF1861BFECQ47882583-605BF2E8-9814-491C-8410-3D236A214932Q58388992-F47A4C52-18B7-4387-8E6B-12B15316F974
P2860
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@ast
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@en
type
label
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@ast
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@en
prefLabel
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@ast
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@en
P356
P1476
Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
@en
P2093
P304
P356
10.1006/BBRC.1999.1972
P407
P577
2000-03-01T00:00:00Z